Your browser doesn't support javascript.
loading
A Pharmacokinetic Analysis of Tobramycin in Patients Less than Five Years of Age with Cystic Fibrosis: Assessment of Target Attainment with Extended-Interval Dosing through Simulation.
Downes, Kevin J; Grim, Austyn; Shanley, Laura; Rubenstein, Ronald C; Zuppa, Athena F; Gastonguay, Marc R.
Afiliación
  • Downes KJ; Division of Infectious, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Grim A; Center for Clinical Pharmacology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Shanley L; Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Rubenstein RC; Department of Pediatrics, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Zuppa AF; Department of Pharmacy, Texas Children's Hospital, Houston, Texas, USA.
  • Gastonguay MR; Clinical Pharmacy, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Antimicrob Agents Chemother ; 66(5): e0237721, 2022 05 17.
Article en En | MEDLINE | ID: mdl-35481751

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tobramicina / Fibrosis Quística Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tobramicina / Fibrosis Quística Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos